 |
171 Diseases |  |
26 Trials |
|
26 Trials |  |
2441 News |  |
| «12...9101112131415161718192021» |
- omega-3 ethylester concentrate / Generic mfg.
Enrollment closed: Age-related Macular Degeneration (AMD) in the Vitamin D and Omega-3 Trial (VITAL) (clinicaltrials.gov) - May 28, 2014
P=N/A, N=25875, Active, not recruiting, Sponsor: Brigham and Women's Hospital
Enrolling by invitation --> Active, not recruiting
- |||| omega-3 ethylester concentrate / Generic mfg.
Trial primary completion date: An Efficacy and Safety Study of Omacor (clinicaltrials.gov) - May 15, 2014
P3, N=253, Completed, Sponsor: Excelsior
Enrolling by invitation --> Active, not recruiting Trial primary completion date: Jun 2013 --> Jul 2013
- ||| omega-3 ethylester concentrate / Generic mfg.
Trial completion date: An Efficacy and Safety Study of Omacor (clinicaltrials.gov) - May 15, 2014
P3, N=253, Completed, Sponsor: Excelsior
Trial primary completion date: Jun 2013 --> Jul 2013 Trial completion date: Sep 2013 --> Aug 2013
- ||||||| omega-3 ethylester concentrate / Generic mfg.
Trial completion: An Efficacy and Safety Study of Omacor (clinicaltrials.gov) - May 15, 2014
P3, N=253, Completed, Sponsor: Excelsior
Trial completion date: Sep 2013 --> Aug 2013 Active, not recruiting --> Completed
- metformin / Generic mfg., rosiglitazone / Generic mfg., omega-3 ethylester concentrate / Generic mfg.
Trial primary completion date: Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM (clinicaltrials.gov) - May 1, 2014
P=N/A, N=146, Completed, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed Trial primary completion date: Jun 2009 --> Aug 2012
- metformin / Generic mfg., rosiglitazone / Generic mfg., omega-3 ethylester concentrate / Generic mfg.
Trial completion date: Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM (clinicaltrials.gov) - May 1, 2014
P=N/A, N=146, Completed, Sponsor: Washington University School of Medicine
Trial primary completion date: Jun 2009 --> Aug 2012 Trial completion date: Dec 2011 --> Sep 2012
- metformin / Generic mfg., rosiglitazone / Generic mfg., omega-3 ethylester concentrate / Generic mfg.
Trial completion: Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM (clinicaltrials.gov) - May 1, 2014
P=N/A, N=146, Completed, Sponsor: Washington University School of Medicine
Trial completion date: Dec 2011 --> Sep 2012 Active, not recruiting --> Completed
- | omega-3 ethylester concentrate / Generic mfg.
Trial completion: Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia (clinicaltrials.gov) - Apr 28, 2014
P4, N=40, Completed, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment closed: VITAL: Study of Vitamin D and Omega-3 Supplementation for Preventing Diabetes (clinicaltrials.gov) - Apr 14, 2014
P=N/A, N=1000, Active, not recruiting, Sponsor: Brigham and Women's Hospital
Recruiting --> Completed Enrolling by invitation --> Active, not recruiting
- omega-3 ethylester concentrate / Generic mfg.
Enrollment closed: VITAL-Echo: Impact of Vitamin D Supplementation on Cardiac Structure and Function (clinicaltrials.gov) - Apr 8, 2014
P=N/A, N=1000, Active, not recruiting, Sponsor: Massachusetts General Hospital
Enrolling by invitation --> Active, not recruiting Enrolling by invitation --> Active, not recruiting
- omega-3 ethylester concentrate / Generic mfg.
Enrollment closed: HOST: The Impact of Omega Three Fatty Acids on Vascular Function in HIV (clinicaltrials.gov) - Apr 8, 2014
P4, N=150, Active, not recruiting, Sponsor: Christine A. Wanke
Enrolling by invitation --> Active, not recruiting Recruiting --> Active, not recruiting
- omega-3 ethylester concentrate / Generic mfg.
Enrollment change: LungVITamin D and OmegA-3 Trial (lungVITAL) (clinicaltrials.gov) - Apr 7, 2014
P=N/A, N=25875, Active, not recruiting, Sponsor: Brigham and Women's Hospital
Recruiting --> Active, not recruiting N=20000 --> 25875
- omega-3 ethylester concentrate / Generic mfg.
Enrollment closed: LungVITamin D and OmegA-3 Trial (lungVITAL) (clinicaltrials.gov) - Apr 7, 2014
P=N/A, N=25875, Active, not recruiting, Sponsor: Brigham and Women's Hospital
N=20000 --> 25875 Enrolling by invitation --> Active, not recruiting
- omega-3 ethylester concentrate / Generic mfg.
Enrollment change: COGNUTRIN in Breast Cancer Survivors (clinicaltrials.gov) - Mar 10, 2014
P=N/A, N=40, Recruiting, Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Enrolling by invitation --> Active, not recruiting N=20 --> 40
- omega-3 ethylester concentrate / Generic mfg.
Enrollment open: COGNUTRIN in Breast Cancer Survivors (clinicaltrials.gov) - Feb 18, 2014
P=N/A, N=40, Recruiting, Sponsor: H. Lee Moffitt Cancer Center and Research Institute
N=20 --> 40 Not yet recruiting --> Recruiting
- omega-3 ethylester concentrate / Generic mfg.
Trial initiation date: PRONOVA: Effects of a Prescription Omega-3 Fatty Acid Concentrate on Induced Inflammation (clinicaltrials.gov) - Jan 28, 2014
P=N/A, N=20, Not yet recruiting, Sponsor: Penn State University
Not yet recruiting --> Recruiting Initiation date: Jun 2013 --> Mar 2014
- omega-3 ethylester concentrate / Generic mfg.
Trial completion: The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease (clinicaltrials.gov) - Jan 21, 2014
P3, N=50, Completed, Sponsor: University of Edinburgh
Initiation date: Jun 2013 --> Mar 2014 Recruiting --> Completed
- |||||||||| atorvastatin / Generic mfg., omega-3 ethylester concentrate / Generic mfg.
New P3 trial, Monotherapy: Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type ?b Hyperlipidemia (clinicaltrials.gov) - Jan 12, 2014
P3, N=80, Recruiting, Sponsor: Kuhnil Pharmaceutical Co., Ltd.
- omega-3 ethylester concentrate / Generic mfg.
Biomarker, Enrollment change: Breast Cancer Risk Biomarkers in Premenopausal Women (clinicaltrials.gov) - Dec 16, 2013
P2, N=36, Completed, Sponsor: Carol Fabian, MD
Recruiting --> Completed N=30 --> 36
- | omega-3 ethylester concentrate / Generic mfg.
Biomarker, Trial completion: Breast Cancer Risk Biomarkers in Postmenopausal Women (clinicaltrials.gov) - Dec 16, 2013
P2, N=35, Completed, Sponsor: Carol Fabian, MD
N=30 --> 36 Active, not recruiting --> Completed
- omega-3 ethylester concentrate / Generic mfg.
Biomarker, Trial completion: Breast Cancer Risk Biomarkers in Premenopausal Women (clinicaltrials.gov) - Dec 16, 2013
P2, N=36, Completed, Sponsor: Carol Fabian, MD
Active, not recruiting --> Completed Active, not recruiting --> Completed
- || omega-3 ethylester concentrate / Generic mfg.
Enrollment closed: Omacor Plus Standard Therapies In Post Myocardial Infarction (MI) Subjects Evaluation: The OPTIMISE Observational Study (clinicaltrials.gov) - Dec 11, 2013
P=N/A, N=1695, Active, not recruiting, Sponsor: Abbott
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | omega-3 ethylester concentrate / Generic mfg.
New P4 trial: Fish Oils and Adipose Inflammation Reduction (clinicaltrials.gov) - Dec 10, 2013
P4, N=52, Not yet recruiting, Sponsor: University of Pennsylvania
- omega-3 ethylester concentrate / Generic mfg.
Trial initiation date: ORENTRA: The Effects of Omega-3 Fatty Acids in Renal Transplantation (clinicaltrials.gov) - Nov 20, 2013
P4, N=132, Recruiting, Sponsor: Oslo University Hospital
Recruiting --> Active, not recruiting Initiation date: Jan 2013 --> Nov 2013
- omega-3 ethylester concentrate / Generic mfg.
Enrollment open: ORENTRA: The Effects of Omega-3 Fatty Acids in Renal Transplantation (clinicaltrials.gov) - Nov 20, 2013
P4, N=132, Recruiting, Sponsor: Oslo University Hospital
Initiation date: Jan 2013 --> Nov 2013 Not yet recruiting --> Recruiting
- omega-3 ethylester concentrate / Generic mfg.
Trial withdrawal: Use of Omega-3 Fatty Acids (Fish Oil) in Patients With Chronic Hepatitis C Infection (clinicaltrials.gov) - Sep 12, 2013
P=N/A, N=0, Withdrawn, Sponsor: Truman Medical Center
Not yet recruiting --> Recruiting Terminated --> Withdrawn
- omega-3 ethylester concentrate / Generic mfg.
Enrollment change: Use of Omega-3 Fatty Acids (Fish Oil) in Patients With Chronic Hepatitis C Infection (clinicaltrials.gov) - Sep 12, 2013
P=N/A, N=0, Withdrawn, Sponsor: Truman Medical Center
Terminated --> Withdrawn N=200 --> 0
- | omega-3 ethylester concentrate / Generic mfg.
Enrollment closed, Surgery: Pilot Study of Lovaza (Omega 3 Fatty Acids) to Improve Cardiac Antioxidant/Anti-inflammatory Profile Before Cardiac Surgery (clinicaltrials.gov) - Sep 5, 2013
P4, N=24, Active, not recruiting, Sponsor: East Carolina University
N=200 --> 0 Recruiting --> Active, not recruiting
- |||| pradigastat (LCQ908) / Novartis
Trial completion, Combination therapy: A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza (clinicaltrials.gov) - Aug 28, 2013
P2, N=58, Completed, Sponsor: Novartis Pharmaceuticals
Recruiting --> Active, not recruiting Recruiting --> Completed
- omega-3 ethylester concentrate / Generic mfg.
Enrollment open, IO biomarker: Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention (clinicaltrials.gov) - Aug 20, 2013
P2, N=150, Recruiting, Sponsor: Vanderbilt University
Recruiting --> Completed Not yet recruiting --> Recruiting
- | omega-3 ethylester concentrate / Generic mfg.
Trial completion: Effects of Prescription Omega-3 Acids on Glucose and Lipoprotein Lipids in Subjects With Hypertriglyceridemia (clinicaltrials.gov) - Aug 13, 2013
P=N/A, N=23, Completed, Sponsor: Provident Clinical Research
Not yet recruiting --> Recruiting Not yet recruiting --> Completed
- | omega-3 ethylester concentrate / Generic mfg.
Trial completion, MRI: OmegaREMODEL: Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging (clinicaltrials.gov) - Jul 29, 2013
P3, N=374, Completed, Sponsor: Brigham and Women's Hospital
Not yet recruiting --> Completed Recruiting --> Completed
- omega-3 ethylester concentrate / Generic mfg.
Enrollment closed: Dietary Fish and Omega 3 Fatty Acids for Breast Cancer Prevention (clinicaltrials.gov) - Jul 24, 2013
P1, N=25, Active, not recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Recruiting --> Completed Completed --> Active, not recruiting
- omega-3 ethylester concentrate / Generic mfg.
Enrollment open: Effects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese Women (clinicaltrials.gov) - Jul 8, 2013
P=N/A, N=30, Recruiting, Sponsor: University of Colorado, Denver
Completed --> Active, not recruiting Not yet recruiting --> Recruiting
- | omega-3 ethylester concentrate / Generic mfg.
Trial completion: LEAP: Lovaza's Effect on the Activation of Platelets (clinicaltrials.gov) - Jun 26, 2013
P2, N=43, Completed, Sponsor: Invitrox
Not yet recruiting --> Recruiting Recruiting --> Completed
- || omega-3 ethylester concentrate / Generic mfg.
Enrollment change: Fish Oil and Muscle Function (clinicaltrials.gov) - Jun 17, 2013
P=N/A, N=90, Recruiting, Sponsor: Washington University School of Medicine
Recruiting --> Completed N=60 --> 90
- omega-3 ethylester concentrate / Generic mfg.
Enrollment change: Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH) (clinicaltrials.gov) - Jun 17, 2013
P2, N=12, Terminated, Sponsor: University of Illinois at Chicago
N=60 --> 90 N=24 --> 12
- niacin extended-release formulation / Generic mfg., omega-3 ethylester concentrate / Generic mfg.
Enrollment change: Niacin, N-3 Fatty Acids and Insulin Resistance (clinicaltrials.gov) - Apr 29, 2013
P4, N=10, Completed, Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
N=24 --> 12 N=60 --> 10
- niacin extended-release formulation / Generic mfg., omega-3 ethylester concentrate / Generic mfg.
Trial completion: Niacin, N-3 Fatty Acids and Insulin Resistance (clinicaltrials.gov) - Apr 29, 2013
P4, N=10, Completed, Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
N=60 --> 10 Active, not recruiting --> Completed
- ||||| omega-3 ethylester concentrate / Generic mfg.
Enrollment closed: An Efficacy and Safety Study of Omacor (clinicaltrials.gov) - Apr 7, 2013
P3, N=249, Active, not recruiting, Sponsor: Excelsior
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | omega-3 ethylester concentrate / Generic mfg.
Enrollment open: Omega-3 Fatty Acids and Insulin Sensitivity (clinicaltrials.gov) - Apr 4, 2013
P3, N=40, Recruiting, Sponsor: Mayo Clinic
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- paclitaxel / Generic mfg.
Clinical: Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel (clinicaltrials.gov) - Mar 28, 2013
P=N/A, N=60, Recruiting, Sponsor: New Mexico Cancer Care Alliance
- omega-3 ethylester concentrate / Generic mfg.
Clinical: PRONOVA: Effects of a Prescription Omega-3 Fatty Acid Concentrate on Induced Inflammation (clinicaltrials.gov) - Mar 14, 2013
P=N/A, N=20, Not yet recruiting, Sponsor: Penn State University
- ||| omega-3 ethylester concentrate / Generic mfg.
New P3 trial: Effect of Omega-3 Fatty Acid on Endothelial Function (clinicaltrials.gov) - Mar 14, 2013
P3, N=50, Not yet recruiting, Sponsor: Nordlandssykehuset HF
- | omega-3 ethylester concentrate / Generic mfg.
Enrollment open: Lovaza Mechanisms of Action (clinicaltrials.gov) - Feb 20, 2013
P4, N=40, Recruiting, Sponsor: Brigham and Women's Hospital
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- omega-3 ethylester concentrate / Generic mfg.
Biomarker: Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue (clinicaltrials.gov) - Feb 3, 2013
P0, N=2080, Not yet recruiting, Sponsor: Milton S. Hershey Medical Center
- pitavastatin / Generic mfg.
Enrollment closed: Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention (clinicaltrials.gov) - Jan 29, 2013
P=N/A, N=372, Active, not recruiting, Sponsor: Milton S. Hershey Medical Center
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- omega-3 ethylester concentrate / Generic mfg.
New P4 trial: Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD (clinicaltrials.gov) - Jan 27, 2013
P4, N=15, Terminated, Sponsor: Maimonides Medical Center
- omega-3 ethylester concentrate / Generic mfg.
Enrollment closed: Evaluating the Effectiveness of Fish Oil Supplements at Reducing the Recurrence of Atrial Fibrillation (clinicaltrials.gov) - Jan 8, 2013
P4, N=450, Active, not recruiting, Sponsor: Vanderbilt University
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | omega-3 ethylester concentrate / Generic mfg.
New P4 trial: ORENTRA: The Effects of Omega-3 Fatty Acids in Renal Transplantation (clinicaltrials.gov) - Dec 4, 2012
P4, N=132, Recruiting, Sponsor: Oslo University Hospital